JAK inhibitors for the treatment of autoimmune and inflammatory diseases
Y Jamilloux, T El Jammal, L Vuitton… - Autoimmunity …, 2019 - Elsevier
Cytokines play a central role in the pathophysiology of autoimmune and inflammatory
diseases. Several cytokines signal through the JAK-STAT pathway, which is now recognized …
diseases. Several cytokines signal through the JAK-STAT pathway, which is now recognized …
[HTML][HTML] JAK inhibitors and autoimmune rheumatic diseases
M Benucci, P Bernardini, C Coccia, R De Luca… - Autoimmunity …, 2023 - Elsevier
The four Janus kinase (JAK) proteins and the seven Signal Transducers of Activated
Transcription (STAT) mediate intracellular signal transduction downstream of cytokine …
Transcription (STAT) mediate intracellular signal transduction downstream of cytokine …
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases
Cytokines are major drivers of autoimmunity, and biologic agents targeting cytokines have
revolutionized the treatment of immune-mediated diseases. Despite the effectiveness of …
revolutionized the treatment of immune-mediated diseases. Despite the effectiveness of …
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
E Favoino, M Prete, G Catacchio, P Ruscitti… - Autoimmunity …, 2021 - Elsevier
The Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway is
an important intracellular route through which many different extracellular soluble …
an important intracellular route through which many different extracellular soluble …
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
GE Fragoulis, IB McInnes, S Siebert - Rheumatology, 2019 - academic.oup.com
Janus kinase (JAK)/signal transducers and activators of transcription (STATs) are a group of
molecules associated with one of the major pathways through which many cytokines exert …
molecules associated with one of the major pathways through which many cytokines exert …
JAK inhibitors for the treatment of rheumatoid arthritis
A Morinobu - Immunological medicine, 2020 - Taylor & Francis
The treatment of rheumatoid arthritis has changed dramatically over the last two decades
since the development of biological disease-modifying anti-rheumatic drugs (bDMARDs) …
since the development of biological disease-modifying anti-rheumatic drugs (bDMARDs) …
Janus kinase inhibitors in autoimmune diseases
Biological therapies directed at proinflammatory cytokines have irrevocably changed the
landscape of treatment of rheumatoid arthritis (RA) and other autoimmune diseases. With …
landscape of treatment of rheumatoid arthritis (RA) and other autoimmune diseases. With …
[HTML][HTML] JAK/STAT pathway in pathology of rheumatoid arthritis
DA Ciobanu, IS Poenariu… - Experimental and …, 2020 - spandidos-publications.com
Rheumatoid arthritis (RA) is classified as an inflammatory, chronic autoimmune and
disabling disease based on the intricate interplay between environmental and genetic …
disabling disease based on the intricate interplay between environmental and genetic …
A decade of JAK inhibitors: what have we learned and what may be the future?
C Liu, J Kieltyka, R Fleischmann… - Arthritis & …, 2021 - Wiley Online Library
The discovery of cytokines and their role in immune and inflammatory disease led to the
development of a plethora of targeted biologic therapies. Later, efforts to understand …
development of a plethora of targeted biologic therapies. Later, efforts to understand …
Selective Janus kinase inhibitors come of age
Janus kinase (JAK) inhibitors (jakinibs) that target downstream signalling by a large range of
cytokines are effective in treating autoimmune and rheumatic diseases. Newer jakinibs that …
cytokines are effective in treating autoimmune and rheumatic diseases. Newer jakinibs that …